NYSE:OCR - Omnicare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$97.90
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Omnicare, Inc. is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG), each serving different customer populations. Through LTC, the Company is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. As of December 31, 2014, LTC provided pharmacy services in the United States in 47 states and the District of Columbia. The Specialty Care Group (SCG) operates across a spectrum of the healthcare continuum, serving the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its SCG services are primarily focused on the specialty pharmaceutical market and incorporate four platforms: brand support services, supply chain solutions, patient support services and specialty pharmacy.

Receive OCR News and Ratings via Email

Sign-up to receive the latest news and ratings for OCR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry N/A
Sub-IndustryHealth Care Services
SectorN/A
Current SymbolNYSE:OCR
Previous Symbol
CUSIP68190410
Phone+1-513-7192600

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

Omnicare (NYSE:OCR) Frequently Asked Questions

What is Omnicare's stock symbol?

Omnicare trades on the New York Stock Exchange (NYSE) under the ticker symbol "OCR."

Has Omnicare been receiving favorable news coverage?

Media headlines about OCR stock have trended very positive this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Omnicare earned a news sentiment score of 4.0 on InfoTrie's scale. They also gave news coverage about the healthcare company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future.

How do I buy shares of Omnicare?

Shares of OCR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Omnicare's official website?

The official website for Omnicare is http://www.omnicare.com/.

How can I contact Omnicare?

Omnicare's mailing address is 900 Omnicare Center 201 E. Fourth Street, CINCINNATI, OH 45202-4248, United States. The healthcare company can be reached via phone at +1-513-7192600.


MarketBeat Community Rating for Omnicare (NYSE OCR)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  130 (Vote Outperform)
Underperform Votes:  128 (Vote Underperform)
Total Votes:  258
MarketBeat's community ratings are surveys of what our community members think about Omnicare and other stocks. Vote "Outperform" if you believe OCR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel